Promega
Promega Corporation, a leading biotechnology company headquartered in the United States, has been at the forefront of life sciences since its founding in 1978. With a strong presence in North America, Europe, and Asia, Promega focuses on providing innovative solutions for molecular biology, genomics, and protein analysis. The company is renowned for its core products, including luciferase-based assays, DNA and RNA purification kits, and cell culture reagents, which are distinguished by their reliability and ease of use. Promega's commitment to quality and innovation has solidified its position as a trusted partner in research and development across various industries, including pharmaceuticals, diagnostics, and academic research. Notable achievements include numerous patents and a robust portfolio that supports advancements in scientific discovery, making Promega a pivotal player in the global biotechnology landscape.
DitchCarbon Score
How does Promega's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Promega's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Promega's reported carbon emissions
In 2022, Promega Corporation reported emissions data indicating a trend towards sustainability, although specific absolute emissions figures were not disclosed. The company operates under the pharmaceutical, biotechnology, and life sciences sector and has committed to reducing its carbon footprint. Notably, Promega has set near-term targets as part of its climate commitments, demonstrating a proactive approach to environmental responsibility. Promega's emissions per million in revenue for 2021 was approximately 0.0304 tonnes CO2e, a slight increase from about 0.0268 tonnes CO2e in 2020. This indicates a need for further action to achieve significant reductions. The company has not disclosed specific Scope 1, 2, or 3 emissions data, which limits the visibility of its overall carbon impact. The organisation is committed to near-term targets, as confirmed by the Science Based Targets initiative (SBTi), although no long-term targets or net-zero commitments have been established as of the latest update. Promega's climate strategy reflects a growing awareness of the need for corporate responsibility in addressing climate change, aligning with industry standards and expectations. Overall, while Promega has made strides in its climate commitments, the absence of detailed emissions data highlights an area for improvement in transparency and accountability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Promega is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
